Asim N. Cheema, MD, PhD

Case Report

Side-Strut Stenting Technique for the Treatment of Aorto-Ostial In-Stent Restenosis and Deformed Stent Struts

08/01/2008

Percutaneous coronary interventions of aorto-ostial lesions, de novo or restenotic, are technically difficult and associated with a higher risk of procedural complications and poor long-term outcome.1–4 To reduce elastic recoil and improve...

Percutaneous coronary...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Comparison of Abciximab and Eptifibatide on Angiographic and Clinical Outcomes in (FULL TITLE BELOW)

08/05/2010

Affan Irfan , MBBS;

Jo-Ann Christie , BSc;

Michael J.B. Kutryk , MD, PhD;

Robert J. Chisholm , MD, FRCPC;

Asim N. Cheema , MD, PhD;

Alan J. Bagnall , MBChB, PhD;

Atif Mohammad , MD;

Tony Hong , BSc;

Waseem Sharieff , MD, PhD;

Ravi R. Bajaj , MD;

NULL

08/05/2010

Journal of Invasive Cardiology

Review

Post-Traumatic Ventricular Septal Defects ‚Äî Review of the Literature and a Novel Technique for Percutaneous Closure

09/01/2009

Robert J. Chisholm , MD, FRCPC;

Asim N. Cheema , MD, PhD;

Reda Ibrahim , MD;

Nicholas J. Collins , BMed, FRACP, MD;

Payam Dehghani , MD, FRCPC;

David Latter , MD;

ABSTRACT: Post-traumatic ventricular septal defect (VSD) is infrequent, with clinical sequelae ranging from imminent death to complete spontaneous resolution. The most appropriate management strategy is unclear. Careful observation has been...

ABSTRACT: Post-traumatic...

09/01/2009

Journal of Invasive Cardiology

Original Contribution

Treatment of Drug-Eluting Stent In-Stent Restenosis With Drug-Eluting Balloons: A Systematic Review and Meta-Analysis

08/15/2018

Naresh Kumar , MD;

Asim N. Cheema , MD, PhD;

Akshay Bagai , MD, MHS;

Bobby Yanagawa , MD, PhD;

Christopher E. Buller , MD, FRCPC, FACC;

Shuangbo Liu , MD;

Mali Worme , MD;

To evaluate the efficacy of drug-coated balloon (DEB) for the treatment of drug-eluting stent in-stent restenosis.

To evaluate the efficacy of...

08/15/2018

Journal of Invasive Cardiology

Original Contribution

Short Duration vs Standard Duration of Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention With Second-Generation Drug-Eluting Stents – A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Randomized Controlled Trials

09/15/2016

Jacob A. Udell , MD, MPH;

Shaun G. Goodman , MD, MSc;

Asim N. Cheema , MD, PhD;

Akshay Bagai , MD, MHS;

Anthony W.A. Wassef , MD;

Hadi Khafaji ;

Ishba Syed ;

Andrew T. Yan , MD;

Current guidelines recommend 12 months of dual-antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation. We investigate whether the duration of DAPT can be safely shortened with use...

Current guidelines recommend 12...

09/15/2016

Journal of Invasive Cardiology

Efficacy and Long-Term Safety of StarClose™ for Hemostasis of Arterial Puncture Sites Distal to Common Femoral Artery Bifurcation After Percutaneous Coronary Interventions

12/02/2010

Payam Dehghani , MD, FRCPC;

Asim N. Cheema , MD, PhD;

Tony Hong , BSc;

Atif Mohammad , MD;

Danny Marcuzzi , MD;

Kate Holmes , RVT;

Melma Jean S. Evangelista , BSc, RVT, RDCS;